Randomized trial testing non-specific effects of BCG vaccine initiated in Australia

In Melbourne, Australia, a randomized trial testing the non-specific effects of BCG vaccine in newborns has now been initiated by Nigel Curtis and colleagues.

We look forward to hearing the results of this ”younger sister” to the ”Calmette-study" (www.calmette-studiet.dk) launched by CVIVA, a study that already enrolled 3200 Danish newborns.

An interesting difference between the Melbourne trial and the Calmette-trial is that Australia uses hepatitis B vaccine at birth; it may be that the effect of BCG differs depending on whether the child also receives other vaccines.

Read more about the Melbourne trial at http://misbair.org.au/